Absence of functional compensation between coagulation factor VIII and plasminogen in double-knockout mice
- 20 November 2018
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 2 (22) , 3126-3136
Abstract
Plasminogen deficiency is associated with severely compromised fibrinolysis and extravascular deposition of fibrin. In contrast, coagulation factor VIII (FVIII) deficiency leads to prolonged and excessive bleeding. Based on opposing biological functions of plasminogen and FVIII deficiencies, we hypothesized that genetic elimination of FVIII would alleviate the systemic formation of fibrin deposits associated with plasminogen deficiency and, in turn, elimination of plasminogen would limit bleeding symptoms associated with FVIII deficiency. Mice with single and combined deficiencies of FVIII (F8−/−) and plasminogen (Plg−/−) were evaluated for phenotypic characteristics of plasminogen deficiency, including wasting disease, shortened lifespan, rectal prolapse, and multiorgan fibrin deposition. Conversely, to specifically examine the role of plasmin-mediated fibrinolysis on bleeding caused by FVIII deficiency, F8−/− and F8−/−/Plg−/− mice were subjected to a bleeding challenge. Mice with a combined deficiency in FVIII and plasminogen displayed no phenotypic differences relative to mice with single FVIII or plasminogen deficiency. Plg−/− and F8−/−/Plg−/− mice exhibited the same penetrance and severity of wasting disease, rectal prolapse, extravascular fibrin deposits, and reduced viability. Furthermore, following a tail vein–bleeding challenge, no significant differences in bleeding times or total blood loss could be detected between F8−/− and F8−/−/Plg−/− mice. Moreover, F8−/− and F8−/−/Plg−/− mice responded similarly to recombinant FVIII (rFVIII) therapy. In summary, the pathological phenotype of Plg−/− mice developed independently of FVIII-dependent coagulation, and elimination of plasmin-driven fibrinolysis did not play a significant role in a nonmucosal bleeding model in hemophilia A mice. Key Points The pathological phenotype associated with plasminogen deficiency developed even in the context of complete FVIII deficiency. The bleeding phenotype and response to rFVIII therapy of F8−/− mice were unaffected by concurrent congenital plasminogen deficiency. Visual AbstractKeywords
This publication has 70 references indexed in Scilit:
- Hepatocyte tissue factor activates the coagulation cascade in miceBlood, 2013
- Consensus recommendations for the use of FEIBA® in haemophilia A patients with inhibitors undergoing elective orthopaedic and non‐orthopaedic surgeryHaemophilia, 2012
- Guidelines for the management of hemophiliaHaemophilia, 2012
- Extramedullary Hematopoiesis: A New Look at the Underlying Stem Cell Niche, Theories of Development, and Occurrence in AnimalsVeterinary Pathology, 2012
- Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia AHaemophilia, 2011
- Discordant fibrin formation in hemophiliaJournal of Thrombosis and Haemostasis, 2009
- Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brainBlood, 2009
- Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A miceJournal of Thrombosis and Haemostasis, 2008
- Plasminogen deficiencyJournal of Thrombosis and Haemostasis, 2007
- Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin αMβ2 binding motifJournal of Clinical Investigation, 2007